Topic: Microbial Dysbiosis in Chronic Inflammatory Diseases

Microbial dysbiosis has emerged as a crucial focal point in the exploration of chronic inflammatory diseases. The pathogenesis of these diseases involves multifaceted mechanisms, with the dynamic equilibrium of the microbiota playing a pivotal role. This Special Issue aims to provide a comprehensive academic platform for studies delving into how microbial dysbiosis influences the development of chronic inflammatory diseases. This encompasses the diversity in the structure and functionality of the microbiota, the intricate interplay between the immune system and microbes, and the distinctive manifestations of dysbiosis in various disease contexts. The objective of this Special Issue is to provide researchers with an in-depth understanding of the connection between microbial dysbiosis and chronic inflammatory disorders, promoting a thorough investigation of the complexities in this area:  

1. Microbiota Structure and Function: Analyzing the variations in the microbiota during chronic inflammatory diseases, with a particular emphasis on the specific structural and functional changes in microbiota across different disease backgrounds; 

2. Immune Regulation and Disease Progression: Exploring the regulatory role of microbial dysbiosis on the host immune system and examining how this regulation influences the development of chronic inflammatory diseases; 

3. Therapeutic Strategies and Prevention: Assessing treatment methods for adjusting microbial dysbiosis, including the use of probiotics, prebiotics, and fecal microbiota transplantation, and exploring their potential applications in the management of chronic inflammatory diseases; 

4. Antibiotic Use and the Relationship with Microbial Dysbiosis: Analyzing the impact of antibiotic use on the microbial ecosystem and investigating its potential implications in the context of chronic inflammatory diseases;

5. Individual Differences and Biodiversity: Examining the variations in the microbiota among different individuals and assessing how these differences shape the presentation and progression of chronic inflammatory diseases;

    etc.